Rapid eye movement sleep behavior disorder as a biomarker for neurodegeneration: The past 10years

Sleep Medicine

Volumn 14, Issue 8, 2013, Pages 763-767

  Postuma, Ronald B ^a,b   Gagnon, Jean Francois ^b,c   Montplaisir, Jacques ^b,d  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Dementia with Lewy Bodies; Neuroprotection; Parkinson's disease; Prediction; REM sleep behavior disorder

Indexed keywords

DOPAMINE; SYNUCLEIN;

ANOSMIA; ANXIETY; AUTONOMIC DYSFUNCTION; BRAIN BLOOD FLOW; BRAIN SIZE; COGNITIVE DEFECT; COLOR VISION; DEPRESSION; DIFFUSE LEWY BODY DISEASE; DIFFUSION TENSOR IMAGING; DOPAMINERGIC SYSTEM; DRUG RESEARCH; ECHOGRAPHY; ELECTROENCEPHALOGRAPHY; HUMAN; MILD COGNITIVE IMPAIRMENT; NERVE DEGENERATION; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASOMNIA; PARKINSON DISEASE; PARKINSONISM; PERSONALITY DISORDER; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PRODROMAL SYMPTOM; REVIEW; RISK ASSESSMENT; RISK FACTOR; SHY DRAGER SYNDROME; VISUAL IMPAIRMENT;

DEMENTIA WITH LEWY BODIES; NEUROPROTECTION; PARKINSON'S DISEASE; PREDICTION; REM SLEEP BEHAVIOR DISORDER;

BIOLOGICAL MARKERS; HUMANS; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; REM SLEEP BEHAVIOR DISORDER; RISK FACTORS;

EID: 84881548975     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2012.09.001     Document Type: Review

References (56)

1. Schenck C.H., Bundlie S.R., Mahowald M.W. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 1996, 46(2):388-393.
2. Iranzo A., Molinuevo J.L., Santamaria J., Serradell M., Marti M.J., Valldeoriola F., et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 2006, 5(7):572-577.
3. Postuma R.B., Gagnon J.F., Vendette M., Fantini M.L., Massicotte-Marquez J., Montplaisir J. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 2009, 72(15):1296-1300.
4. Boot B.P., Boeve B.F., Roberts R.O., Ferman T.J., Geda Y.E., Pankratz V.S., et al. Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: a population-based study. Ann Neurol 2012, 71(1):49-56.
5. Iranzo A., Molinuevo J.L., Santamaria J., Serradell M., Marti M.J., Valldeoriola F., et al. Sixty-four percent of patients with idiopathic REM sleep behavior disorder developed a neurological disorder after a mean clinical follow-up of seven years. Sleep 2008, 31:A280.
6. Wing Y.K., Li S.X., Mok V., Lam S.P., Tsoh J., Chan A., et al. Prospective outcome of rapid eye movement sleep behaviour disorder: psychiatric disorders as a potential early marker of Parkinson's disease. J Neurol Neurosurg Psychiatry 2012, 83(4):470-472.
7. Ferman T.J., Boeve B.F., Smith G.E., Lin S.C., Silber M.H., Pedraza O., et al. Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies. Neurology 2011, 77(9):875-882.
8. Boeve B.F., Silber M.H., Parisi J.E., Dickson D.W., Ferman T.J., Benarroch E.E., et al. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology 2003, 61(1):40-45.
9. Postuma R.B., Gagnon J.F., Rompre S., Montplaisir J. Severity of REM atonia loss in idiopathic REM Sleep behavior disorder predicts Parkinson disease. Neurology 2010, 74:239-244.
10. Postuma R.B., Gagnon J.F., Montplaisir J. Clinical prediction of Parkinson's disease - planning for the age of neuroprotection. J Neurol Neurosurg Psychiatry 2010, 81(9):1008-1013.
11. de Lau L.M., Breteler M.M. Epidemiology of Parkinson's disease. Lancet Neurol 2006, 5(6):525-535.
12. Hawkes C.H., Shephard B.C., Daniel S.E. Olfactory dysfunction in Parkinson's disease. J Neurol Neurosurg Psychiatry 1997, 62(5):436-446.
13. Ross G.W., Petrovitch H., Abbott R.D., Tanner C.M., Popper J., Masaki K., et al. Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol 2008, 63(2):167-173.
14. Ponsen M.M., Stoffers D., Twisk J.W., Wolters E.C., Berendse H.W. Hyposmia and executive dysfunction as predictors of future Parkinson's disease: a prospective study. Mov Disord 2009, 24(7):1060-1065.
15. Postuma R.B., Gagnon J.F., Vendette M., Montplaisir J. Markers of neurodegeneration in idiopathic REM sleep behavior disorder and Parkinson disease. Brain 2009, 132(12):2298-2307.
16. Postuma R.B., Lang A.E., Massicotte-Marquez J., Montplaisir J. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 2006, 66(6):845-851.
17. Fantini M.L., Postuma R.B., Montplaisir J., Strambini L.F. Olfactory impairment in idiopathic and symptomatic REM sleep behavior disorder. Brain Res Bull 2006, 16:386-390.
18. Postuma R.B., Gagnon J.F., Vendette M., Desjardins C., Montplaisir J. Olfaction and color vision identify impending neurodegeneration in REM behavior disorder. Ann Neurol 2011, 69(5):811-818.
19. Braak H., Del T.K. Invited article: nervous system pathology in sporadic Parkinson disease. Neurology 2008, 70(20):1916-1925.
20. Braak H., Sastre M., Bohl J.R., de Vos R.A., Del T.K. Parkinson's disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol 2007, 113(4):421-429.
21. Orimo S., Takahashi A., Uchihara T., Mori F., Kakita A., Wakabayashi K., et al. Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease. Brain Pathol 2007, 17(1):24-30.
22. Yoshita M., Taki J., Yokoyama K., Noguchi-Shinohara M., Matsumoto Y., Nakajima K., et al. Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD. Neurology 2006, 66(12):1850-1854.
23. Oka H., Morita M., Onouchi K., Yoshioka M., Mochio S., Inoue K. Cardiovascular autonomic dysfunction in dementia with Lewy bodies and Parkinson's disease. J Neurol Sci 2007, 254(1-2):72-77.
24. Abbott R.D., Petrovitch H., White L.R., Masaki K.H., Tanner C.M., Curb J.D., et al. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001, 57(3):456-462.
25. Savica R., Carlin J.M., Grossardt B.R., Bower J.H., Ahlskog J.E., Maraganore D.M., et al. Medical records documentation of constipation preceding Parkinson disease: a case-control study. Neurology 2009, 73(21):1752-1758.
26. Valappil R.A., Black J.E., Broderick M.J., Carrillo O., Frenette E., Sullivan S.S., et al. Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease. Mov Disord 2010, 25(14):2296-2303.
27. Postuma R.B., Montplaisir J., Lanfranchi P.A., Blais H., Rompre S., Colombo R., et al. Cardiac autonomic denervation in Parkinson's disease is linked to REM sleep behavior disorder. Mov Disord 2011, 26(8):1529-1533.
28. Oka H., Yoshioka M., Onouchi K., Morita M., Mochio S., Suzuki M., et al. Characteristics of orthostatic hypotension in Parkinson's disease. Brain 2007, 130(Pt. 9):2425-2432.
29. Miyamoto T., Miyamoto M., Inoue Y., Usui Y., Suzuki K., Hirata K. Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder. Neurology 2006, 67(12):2236-2238.
30. Morrish P.K., Rakshi J.S., Bailey D.L., Sawle G.V., Brooks D.J. Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET. J Neurol Neurosurg Psychiatry 1998, 64(3):314-319.
31. Ravina B., Eidelberg D., Ahlskog J.E., Albin R.L., Brooks D.J., Carbon M., et al. The role of radiotracer imaging in Parkinson disease. Neurology 2005, 64(2):208-215.
32. Eisensehr I., Linke R., Noachtar S., Schwarz J., Gildehaus F.J., Tatsch K. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls. Brain 2000, 123(Pt. 6):1155-1160.
33. Albin R.L., Koeppe R.A., Chervin R.D., Consens F.B., Wernette K., Frey K.A., et al. Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology 2000, 55(9):1410-1412.
34. Iranzo A., Lomena F., Stockner H., Valldeoriola F., Vilaseca I., Salamero M., et al. Decreased striatal dopamine transporters uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol 2010, 9(11):1070-1077.
35. Gaenslen A., Unmuth B., Godau J., Liepelt I., Di S.A., Schweitzer K.J., et al. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study. Lancet Neurol 2008, 7(5):417-424.
36. Berg D., Merz B., Reiners K., Naumann M., Becker G. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov Disord 2005, 20(3):383-385.
37. Spiegel J., Hellwig D., Mollers M.O., Behnke S., Jost W., Fassbender K., et al. Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease. Brain 2006, 129(Pt. 5):1188-1193.
38. Berg D., Seppi K., Behnke S., Liepelt I., Schweitzer K., Stockner H., et al. Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons. Arch Neurol 2011, 68(7):932-937.
39. Unger M.M., Moller J.C., Stiasny-Kolster K., Mankel K., Berg D., Walter U., et al. Assessment of idiopathic rapid-eye-movement sleep behavior disorder by transcranial sonography, olfactory function test, and FP-CIT-SPECT. Mov Disord 2008, 23(4):596.
40. Stockner H., Iranzo A., Seppi K., Serradell M., Gschliesser V., Sojer M., et al. Midbrain hyperechogenicity in idiopathic REM sleep behavior disorder. Mov Disord 2009, 24(13):1906-1909.
41. Massicotte-Marquez J., Decary A., Gagnon J.F., Vendette M., Mathieu A., Postuma R.B., et al. Executive dysfunction and memory impairment in idiopathic REM sleep behavior disorder. Neurology 2008, 70(15):1250-1257.
42. Ferini-Strambi L., Di Gioia M.R., Castronovo V., Oldani A., Zucconi M., Cappa S.F. Neuropsychological assessment in idiopathic REM sleep behavior disorder (RBD): does the idiopathic form of RBD really exist?. Neurology 2004, 62(1):41-45.
43. Fantini M.L., Gagnon J.F., Petit D., Rompre S., Decary A., Carrier J., et al. Slowing of electroencephalogram in rapid eye movement sleep behavior disorder. Ann Neurol 2003, 53(6):774-780.
44. Iranzo A., Isetta V., Molinuevo J.L., Serradell M., Navajas D., Farre R., et al. Electroencephalographic slowing heralds mild cognitive impairment in idiopathic REM sleep behavior disorder. Sleep Med 2010, 11(6):534-539.
45. Scherfler C., Frauscher B., Schocke M., Iranzo A., Gschliesser V., Seppi K., et al. White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-tensor imaging and voxel-based morphometry study. Ann Neurol 2011, 69(2):400-407.
46. Mazza S., Soucy J.P., Gravel P., Michaud M., Postuma R., Massicotte-Marquez J., et al. Assessing whole brain perfusion changes in patients with REM sleep behavior disorder. Neurology 2006, 67(9):1618-1622.
47. Unger M.M., Belke M., Menzler K., Heverhagen J.T., Keil B., Stiasny-Kolster K., et al. Diffusion tensor imaging in idiopathic REM sleep behavior disorder reveals microstructural changes in the brainstem, substantia nigra, olfactory region, and other brain regions. Sleep 2010, 33(6):767-773.
48. Postuma R.B., Lang A.E., Gagnon J.F., Pelletier A., Montplaisir J.Y. How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder. Brain 2012, 135(Pt. 6):1860-1870.
49. Postuma R.B., Gagnon J.F., Vendette M., Charland K., Montplaisir J. Manifestations of Parkinson disease differ in association with REM sleep behavior disorder. Mov Disord 2008, 23(12):1665-1672.
50. Postuma R.B., Gagnon J.F., Vendette M., Massicotte-Marquez J., Charland K., Montplaisir J. REM sleep behavior disorder in Parkinson's disease is associated with specific motor features. J Neurol Neurosurg Psychiatry 2008, 79(10):1117-1121.
51. Gagnon J.F., Vendette M., Postuma R.B., Desjardins C., Massicotte-Marquez J., Panisset M., et al. Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease. Ann Neurol 2009, 66(1):39-47.
52. Postuma R.B., Bertrand J.A., Montplaisir J., Desjardins C., Vendette M., Rios Romenets S., et al. Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: a prospective study. Mov Disord 2012, 27(6):720-726.
53. Kumru H., Santamaria J., Tolosa E., Iranzo A. Relation between subtype of Parkinson's disease and REM sleep behavior disorder. Sleep Med 2007, 8(7-8):779-783.
54. Stern M.B., Lang A., Poewe W. Toward a redefinition of Parkinson's disease. Mov Disord 2012, 27(1):54-60.
55. Iranzo A., Valldeoriola F., Lomena F., Molinuevo J.L., Serradell M., Salamero M., et al. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol 2011, 10(9):797-805.
56. Bertrand J.A., Postuma R.B., Genier-Marchand D., Montplaisir J., Gagnon J.F. Color discrimination and cognitive impairment in idiopathic REM sleep behavior disorder. Neurology 2012, 78(Suppl. 1):P05004.